Breaking News
Get 40% Off 0
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks! Unlock list
Close

VentriPoint Diagnostics Ltd (VPT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.2500 +0.0300    +13.64%
03/05 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 463,163
  • Bid/Ask: 0.2450 / 0.2500
  • Day's Range: 0.2100 - 0.2500
Type:  Equity
Market:  Canada
VentriPoint Diagnostics 0.2500 +0.0300 +13.64%

VentriPoint Diagnostics Ltd Company Profile

 
Get an in-depth profile of VentriPoint Diagnostics Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Contact Information

Address 18 Hook Avenue Unit 101
Toronto, M6P 1T4
Canada
Phone 416-848-4156
Fax -

Top Executives

Name Age Since Title
George Adams 71 2010 Executive Chairman & Corporate Secretary
Michael Gatzoulis - - Member of Scientific Advisory Board
Richard Krasuski - 2011 Member of Scientific Advisory Board
Samuel Schwartz - 2018 Chair of Business Advisory Committee
Mark Lewin - - Member of Scientific Advisory Board
David Sahn - - Member of Scientific Advisory Board
Scott D. Solomon - 2012 Member of Scientific Advisory Board
Hugh MacNaught - 2020 Interim CEO, President & Director
Randy AuCoin - 2021 Independent Director
Fiona Fitzgerald - 2021 Independent Director
Gregory Skinner - 2022 Member of Board of Clinical Advisors
Luc Mertens - 2024 Member of Clinical Advisory Board
Robert Lloyd Hodgkinson 75 2019 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VPT Comments

Write your thoughts about VentriPoint Diagnostics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email